In the transgenic multicolor labeling strategy called 'Brainbow', Cre-loxP recombination is used to create a stochastic choice of expression among fluorescent proteins, resulting in the indelible marking of mouse neurons with multiple distinct colors. this method has been adapted to non-neuronal cells in mice and to neurons in fish and flies, but its full potential has yet to be realized in the mouse brain. here we present several lines of mice that overcome limitations of the initial lines, and we report an adaptation of the method for use in adenoassociated viral vectors. We also provide technical advice about how best to image Brainbow-expressing tissue.
Improved tools for the Brainbow toolbox
In the transgenic multicolor labeling strategy called 'Brainbow', Cre-loxP recombination is used to create a stochastic choice of expression among fluorescent proteins, resulting in the indelible marking of mouse neurons with multiple distinct colors. this method has been adapted to non-neuronal cells in mice and to neurons in fish and flies, but its full potential has yet to be realized in the mouse brain. here we present several lines of mice that overcome limitations of the initial lines, and we report an adaptation of the method for use in adenoassociated viral vectors. We also provide technical advice about how best to image Brainbow-expressing tissue.
The discovery that recombinant jellyfish GFP fluoresces when expressed in heterologous cells 1 has led to a vast array of powerful methods for marking and manipulating cells, subcellular compartments and molecules. The discovery or design of numerous spectral variants [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] (fluorescent proteins collectively called XFPs; ref. 14) expanded the scope of the 'GFP revolution' by enabling discrimination of nearby cells or processes labeled with contrasting colors. At least for the nervous system, however, two or three colors are far too few because each axon or dendrite approaches hundreds or thousands of other processes in the crowded neuropil of the brain.
Several years ago, we developed a transgenic strategy called Brainbow 15 that addresses this problem by marking neurons with many different colors. In this method, three or four XFPs are incorporated into a transgene, and the Cre-loxP recombination system 16 is used to make a stochastic 'choice' of a single XFP to be expressed from the cassette. Because multiple cassettes are integrated at a single genomic site, and the choice within each cassette is made independently, combinatorial expression can endow individual neurons with 1 of ~100 colors, providing nearby neurons with distinct spectral identities.
If Cre recombinase is expressed transiently, descendants of the initially marked cell inherit the color of their progenitor. Accordingly, the Brainbow method has been adapted for use in lineage analysis in non-neural tissues of mice [17] [18] [19] [20] [21] . In addition, it has been adapted for analyses of neuronal connectivity, cell migration and lineage in fish 22, 23 and flies 24, 25 . In contrast, the method has been little used in the mouse nervous system 26 . We believe that the main reasons for this are limitations of the initial set of Brainbow transgenic mice. These include suboptimal fluorescence intensity, failure to fill all axonal and dendritic processes, and disproportionate expression of the 'default' (that is, nonrecombined) XFP in the transgene. We have now addressed several of these limitations, and we present here a new set of Brainbow reagents. In addition, we provide guidelines for imaging Brainbowexpressing tissue.
RESULtS design of Brainbow 3.0 transgenes
As a first step in improving Brainbow methods, we sought XFPs with minimal tendency to aggregate in vivo, high photostability and maximal stability with respect to paraformaldehyde fixation. Because some XFPs that ranked highly in cultured cells performed poorly in vivo, we generated transgenic lines from 15 XFPs ( Supplementary Table 1 and refs. [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] . Of the XFPs tested in this way, seven were judged suitable: mTFP1, EGFP, EYFP, mOrange2, TagRFPt, tdTomato and mKate2.
From these XFPs, we chose three according to the criteria of minimal spectral overlap and minimal sequence homology. These XFPs were mOrange2 from a coral (excitation peak (Ex) = 549 nm, emission peak (Em) = 565 nm), EGFP from a jellyfish (Ex = 488 nm, Em = 507 nm) and mKate2 from a sea anemone (Ex = 588 nm, Em = 635 nm) 2, 9, 11 . Our reason for minimizing sequence homology was to ensure that the XFPs would be antigenically distinct, in contrast to spectrally distinct but antigenically indistinguishable jellyfish variants (EBFP, ECFP, EGFP and EYFP). Exploiting this property, we generated antibodies to the XFPs in different host species (rabbit anti-mCherry, anti-mOrange2 and anti-tdTomato; chicken anti-EGFP, anti-EYFP and anti-ECFP; and guinea pig anti-mKate2, anti-TagBFP and anti-TagRFP; Supplementary Table 1 ). Tests in transfected cultured cells confirmed a lack of cross-reactivity (data not shown).
Next we addressed the need to fill all parts of the cell evenly. Unmodified XFPs labeled somata so strongly that nearby processes were difficult to resolve, whereas palmitoylated derivatives, which targeted the XFPs to the plasma membrane, were selectively transported to axons and labeled dendrites poorly 15 . We therefore generated farnesylated derivatives 27 , which were trafficked to membranes of all neurites (see below).
On the basis of these results, we generated 'Brainbow 3.0' transgenic lines incorporating farnesylated derivatives of mOrange2, EGFP and mKate2. We retained the Brainbow 1 format 15 , in which incompatible wild-type and mutant loxP sites are concatenated so that Cre recombinase yields a stochastic choice among XFPs ( Fig. 1a) . We also retained two other features of the Brainbow 1 strategy. First, we used neuron-specific regulatory elements from the Thy1 gene 14 because it promotes high levels of transgene expression in many, although not all, neuronal types; other promoter-enhancer sequences that we tested support considerably lower levels of expression 21 . Second, we generated transgenic lines by injection into oocytes because this method leads to integration of multiple copies of the cassette and, thus, a broad spectrum of outcomes 15, 28 ; by contrast, knock-in lines generated by homologous recombination contain one or two copies of the cassette (as heterozygotes or homozygotes, respectively) and, consequently, a smaller number of possible color combinations [17] [18] [19] [20] .
design of Brainbow 3.1 and 3.2 transgenes
In Brainbow 1, 2 and 3.0 ( Fig. 1a) and ref. 15 , one XFP is expressed 'by default' in Cre-negative cells. The presence of a default XFP has both drawbacks and advantages. In cases of limited Cre expression, this XFP is expressed in a majority of cells, reducing spectral diversity among recombined neurons. On the other hand, incorporation of a default XFP allows one to screen numerous lines in the absence of a Cre reporter to assess the number and types of cells in which XFPs could be expressed following recombination.
To eliminate the default XFP while retaining the ability to assess expression in the absence of Cre, we adopted the following strategy. First, we incorporated three rather than two pairs of incompatible loxP sites, which allowed insertion of a 'stop' cassette 29 into a first position. With this modification, the three XFPs were expressed only in Cre-positive neurons, giving more spectral diversity. Second, we inserted a fourth XFP, Phi-YFP (from the hydrozoon Phialidium) 4 , which is antigenically distinct from the other three, into the stop cassette. We mutated Phi-YFP to eliminate its endogenous fluorescence (PhiYFP Y65A), fused it to a nuclear localization sequence and generated antibodies against it in rat. In Brainbow 3.1 mice generated from this cassette ( Fig. 1a ), one can screen sections with rat anti-Phi-YFP before Cre recombination ( Supplementary Fig. 1 ).
Finally, we inserted a sequence that stabilizes mRNAs, called a woodchuck hepatitis virus post-transcriptional regulatory element (WPRE), into the 3′ untranslated sequences following each XFP. The WPRE has been used in many cases to increase protein levels produced by viral vectors and transgenes 30, 31 . We call lines incorporating the WPRE 'Brainbow 3.2' (Fig. 1a ).
Characterization of Brainbow 3 mice
We generated 31 lines of transgenic mice from the Brainbow 3.0, 3.1 and 3.2 cassettes. Offspring were crossed with several Cre transgenic lines [32] [33] [34] [35] [36] [37] , leading to multicolor spectral labeling of neuronal populations in numerous regions including cerebral cortex, brainstem, cerebellum, spinal cord and retina ( Fig. 1b-f , Supplementary  Table 2 , Supplementary Fig. 2 and Supplementary Videos 1 and 2). The intensity of expression varied markedly among lines, making quantitative comparison of dubious value, but the most npg strongly expressing lines were those that incorporated the WPRE (Brainbow 3.2). Analysis of these lines confirmed their advantages over Brainbow 1 and 2 lines 15 . First, the use of farnesylated XFPs led the XFPs to concentrate at the plasma membrane ( Fig. 1d) . As a consequence, somata were less intensely labeled in Brainbow 3 than in Brainbow 1 mice, so processes could be visualized without saturation of the somata (Fig. 2a,b and Supplementary  Fig. 3 ). Use of farnesylated XFPs also improved labeling of fine processes and dendritic spines ( Fig. 2a,b) . Second, the ability to immunostain all three XFPs led to enhancement of the intrinsic fluorescence without loss of color diversity (Fig. 2c,d and Supplementary  Fig. 4 ). Third, XFP fluorescence was visible only in Crepositive cells, thereby correcting the color imbalance caused by default XFP expression in cells that were Cre negative or cells that expressed Cre at low levels in Brainbow 1 and 2 lines ( Fig. 2e-i and Supplementary Fig. 5 ). Thus, Brainbow 3 lines are likely to be more useful than Brainbow 1 and 2 lines for multicolor labeling.
Brainbow with self-excising Cre recombinase
In Brainbow 1-3 lines, the cassette encodes XFPs separated by loxP sites; Cre recombinase is supplied from a separate transgene. For analysis of connectivity in mouse mutants, breeding mice with two transgenes (Brainbow and Cre) into an already complex background is cumbersome. We therefore attempted to combine constructs encoding XFPs and Cre in a single cassette. In this transgene, called ' Autobow' , we substituted a self-excising Cre recombinase 38 for the stop sequences in Brainbow 3.1 (Fig. 3a) . The Thy1 regulatory elements lead to expression of Cre in differentiated neurons; Cre then simultaneously activates an XFP and excises itself.
We generated three founder mice using this construct. Two were analyzed as adults, and both of these exhibited combinatorial expression of XFPs in multiple neurons ( Fig. 3b and Supplementary Fig. 2e ). We were concerned that precocious Cre activation in the germ line might lead to loss of the cassette. We therefore established a line from the third founder and examined mice in the second and sixth generations. Color range was limited in this line, perhaps because only a few copies had been integrated into the genome, but the variety of colors and level of expression were similar in both generations (Fig. 3c,d) . Thus, Autobow transgenes can be stably maintained.
Brainbow using Flp recombinase and FRT sites
A second recombination system, orthogonal to Cre-loxP, could be used to independently control expression of distinct XFPs in, for example, excitatory and inhibitory neurons. In this way, the color of a neuron could denote cell identity, a feature lacking in currently available Brainbow lines 15, [17] [18] [19] [20] . We therefore tested a second recombination system, in which Flp recombinase acts on Flp recombinase target (FRT) sites. The Flp-FRT system has been used in conjunction with Cre-loxP in mice 16 and in Brainbow-like transgenes in Drosophila 24, 25 .
We tested previously described mutant FRT sites 39, 40 to find incompatible sets (Supplementary Fig. 6 ) and used these sets to construct 'Flpbow' lines ( Fig. 4a) . In one cassette, we fused the XFPs to an epitope tag 41 , which allowed for discrimination of cells labeled by Cre-and Flp-driven cassettes (Supplementary Fig. 7) . npg When Flpbow mice were mated to Flp-expressing mice 42, 43 , we observed multicolor labeling (Fig. 4b,c) . Although the few lines tested to date exhibit narrow expression patterns, these results demonstrate that Flp-and Cre-based Brainbow systems can be used in combination.
Brainbow adeno-associated viral vectors
In parallel to developing Brainbow transgenic lines, we generated adeno-associated viral (AAV) vectors to provide spatial and temporal control over expression and to make the method applicable to other species. Because the Brainbow 3.1 cassette described above is >6 kilobase pairs (kb), but the capacity of AAV vectors is <5 kb, we re-engineered the cassette. On the basis of results from initial tests (Supplementary Fig. 8) , we devised a scheme in which loxP sites with left or right element mutations 44 were used for unidirectional Cre-dependent inversion (Fig. 5a,b) . Farnesylated XFPs were positioned in reverse orientation to prevent Cre-independent expression, and WPRE elements were added to increase expression. In this design, recombination can lead to three outcomes from two XFPs: XFP1, XFP2 or neither. We generated two AAVs with two XFPs each, such that co-infection would lead to a minimum of eight hues (3 × 3 -1; Fig. 5c ). Because AAV can infect cells at high multiplicity, the number of possible colors is 8. An additional feature is that excision of the nonexpressed XFP in a second step (Fig. 5a ) enhances and equalizes expression of the remaining XFP (Fig. 5d,e) . We infected cortex, cerebellum and retina of Cre transgenic mice with these vectors. When examined 3-5 weeks later, neurons were labeled in multiple colors (Fig. 5f-j  and Supplementary Video 3) . Near injection sites, high levels of infectivity led to coexpression of all XFPs in single cells so that neurons appeared gray or white. The variety of colors increased with distance from these sites and then decreased again in sparsely injected regions, presumably because each labeled neuron received only one virion (Supplementary Fig. 9 ).
methods to optimize Brainbow imaging
Obtaining high-quality images from of tissues expressing Brainbow transgenes is challenging. Because colors are derived by mixing images of multiple fluorophores over a wide range of concentrations, factors that differentially affect the labels degrade the final image. In addition, it is usually necessary to image a tissue volume rather than a single section, so methods for taking image stacks must be optimized. Here we summarize guidelines for imaging Brainbow tissue.
Sample preparation. To minimize background, section thickness should be less than the working distance of the objective, generally <100 µm for high-numerical aperture (high NA) lenses. It is also important to match the refractive indices of the immersion medium and the sample because chromatic aberrations caused by mismatches between these values lead to spatial offsets between color channels (Supplementary Fig. 10 ). Commercial antifade Confocal laser scanning microscopy. Epifluorescence microscopy can be used for imaging thin sections (<10 µm) or monolayer cultures, but confocal microscopes are preferable for thick specimens because they decrease contamination by light from outside the plane of focus. Newly developed two-photon multi-XFP imaging techniques are also useful [45] [46] [47] . Apochromatic or fluorite microscope objectives that are corrected for three or more colors are strongly recommended. Most lens manufacturers specify preferred oils and coverslips. Using the wrong oil or coverslip degrades the sharpness of focus and increases chromatic aberration. Fluorophores with overlap in the excitation or emission spectra should be imaged sequentially rather than simultaneously to minimize fluorescence cross-talk and thereby optimize color separation. Laser power should be set as low as possible for several reasons. First, all planes are bleached as each image plane is scanned, so generation of stacks leads to gradual bleaching and decreased signal through the stack. Second, because each fluorophore bleaches at a different rate, colors may shift during imaging. Third, linear signaling requires that fluorophores emit photons at submaximal rates; at higher excitation intensities, only the out-of-focus signal is increased 48 . Fourth, if one fluorophore species is saturated but another is not, small changes in laser power will affect the fluorophore intensities differently, leading to color change. With high-NA objectives, a laser power of just a few milliwatts is saturating; this is generally a small percentage of the total power the laser can provide.
With laser power adjusted to a low level, the photomultipliertube voltages and digital gains must be set to relatively high values. In some confocal microscopes it is possible to compensate for signal loss from deep layers through automatic adjustment of laser power, photomultiplier-tube voltage or digital gain as a function of depth. Imaging parameters can be adjusted to obtain images with similar signal ranges throughout the stack.
Image processing. Brainbow images must be postprocessed to maximize color information, but care is needed to avoid introducing artifacts. Often one begins by reducing noise. Because confocal laser scanning of multicolor stacks is generally done at speeds of ~1 µs per pixel or less to save time, the small number of photons collected for each pixel gives rise to sufficient shot noise to cause perceptible local color differences. This problem can be minimized by slower scanning or averaging of multiple scans, but when this is infeasible, simple filtering and deconvolution methods are helpful ( Fig. 6a-c) . For example, median or Gaussian filters with radii of 0.5-2 pixels reduce color noise, but at the expense of resolution. Deconvolution algorithms (Online Methods) are more challenging to use than simple filters but can remove color noise without compromising spatial resolution (Supplementary Fig. 11) .
Subsequent processing steps can expand the detectable color range and correct for color shifts (Fig. 6d,e) . To obtain easily perceived color differences, pixel intensity values for each channel in each image are normalized to the same minimum and maximum intensity values for that color in the whole image stack. This linearly stretches all channels and images to the full dynamic range. Color shifts also arise because illumination strength is generally uneven across the imaging field and differs among lasers. This effect can be attenuated by intensity or shading correction for each channel 46, 49 . The resulting composite RGB images provide maximum color separation for viewing by eye ( Fig. 6f) .
dISCUSSIOn
The goal of the work reported here was to design, generate and characterize improved reagents for multicolor Brainbow imaging of neurons in mice. First, we generated new transgenic lines that overcome some limitations of the Brainbow 1 and 2 lines that are currently available 15 . The improvements were the substitution of XFPs (especially red and orange fluorescent proteins) npg that are more photostable and less prone to aggregation than those used initially; use of XFPs with minimal sequence homology so they could be immunostained separately; farnesylation of the XFPs for even staining of somata and the finest processes; insertion of a stop cassette to increase color variety by eliminating broad expression of a default XFP; inclusion of a nonfluorescent marker in the default position to facilitate screening of multiple lines; and insertion of a WPRE to boost expression ( Figs. 1 and 2) . These lines, which incorporate regulatory elements from the Thy1 gene, enable marking of many but not all neuronal types. To date, elements tested other than those from the Thy1 gene do not support the high expression levels needed to image Brainbow 1 and 2 material. The ability to immunostain provided by Brainbow 3 cassettes may allow weaker promoters to be used. Second, we designed two additional transgenes and performed initial tests to demonstrate that they can be used effectively in vivo. Fig. 10 ). npg One construct, called Autobow, incorporates a self-excising Cre recombinase. Autobow lacks the temporal and spatial control afforded by the use of specific Cre lines or ligand-activated Cre (CreER). However, because it does not require the generation of double transgenics, it may be useful for rapid screening of neuronal morphology in mutant mice or mice submitted to various experimental interventions (such as drug treatments). The other novel transgene, Flpbow, replaces loxP sites with FRT sites so that recombination can be controlled by Flp recombinase rather than Cre recombinase. Flpbow 3 also incorporates an epitope tag so that XFPs in Flpbow can be distinguished immunohistochemically from XFPs in Brainbow. By using Cre and Flp transgenic lines with distinct, defined specificities, it should be possible to map separate sets of neurons in a single animal. Finally, we generated Brainbow AAV vectors. These, along with recently described Brainbow herpes viral vectors 50 , may be more useful than Brainbow transgenic mice in some situations. Similar to Autobow, they avoid the need for double-transgenic animals. Because the time of infection can be varied, these vectors provide an alternative to CreER for temporal control. Moreover, localized delivery of AAVs enables the tracing of connections from known sites to multiple targets and discrimination of longdistance inputs from local connections.
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Methods and any associated references are available in the online version of the paper.
